STUDY SEARCH RESULTS

2 studies found for your search request:  3475-859

Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric o...
Condition: Stomach neoplasms
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT03675737
Status: Completed
Has Results

Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric o...
Condition: Stomach neoplasms
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT04859582
Status: Withdrawn




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site